Cooper Companies | COO - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Abbott USD 6.65B 787M 2026-06
Align Technology USD 757.43M 20.84M 2026-06
AtriCure USD 109.31M 3.97M 2026-03
Bausch Health Companies USD 2.08B 294M 2026-06
Baxter International USD 1.14B 251M 2026-06
Bayer EUR 8.17B 1.24B 2026-03
Becton, Dickinson and Co. USD 2.32B 161M 2026-06
Boston Scientific USD 3.82B 210M 2026-06
Cooper Companies USD 735.4M 40.2M 2026-03
Dentsply International USD 427M 16M 2026-03
Dexcom USD 750.3M 42.4M 2026-03
Edwards Lifesciences USD 1.35B 62.6M 2026-06
Globus Medical USD 548.17M 51.91M 2026-06
Haemonetics USD 202.8M 4.59M 2026-06
Inogen USD 41.34M 1.39M 2024-09
Insulet USD 562.6M 21.8M 2026-06
Integra LifeSciences USD 215.97M 2.77M 2026-06
Intuitive Surgical USD 2.02B 193.4M 2026-06
J&J USD 18.55B 1.31B 2026-06
Medtronic USD 6.01B 595M 2026-03
Merit Medical Systems USD 215.17M 30.37M 2026-06
Novartis USD 10.07B 758M 2026-03
ResMed USD 861.22M 29.76M 2026-06
STAAR Surgical USD 43.74M 34.13M 2025-12
Steris USD 684.2M 12.9M 2026-06
Stryker USD 4.5B 688M 2026-06
Tandem Diabetes Care USD 136.79M 30.67M 2026-03
Teleflex USD 307.43M 21K 2026-03
Utah Medical Products USD 5.8M 450K 2024-09
Zimmer Biomet Holdings USD 1.36B 149.4M 2026-06